Progesterone receptor membrane component 1 increases hormone induced proliferation of breast cancer cells——E2 vs sequential combination vs continuous combination
Li Xue, Ruan Xiangyan, Gu Muqing, Cai Guiju, Zhao Yue, Alfred O. Meuck
2019, 40(2):
237-243.
doi:10.3969/j.issn.1006-7795.2019.02.016
Asbtract
(
90 )
PDF (2998KB)
(
89
)
References |
Related Articles |
Metrics
Objective To investigate the effect of progesterone receptor membrane component 1 (PGRMC1) on the risk of hormone induced breast cancer, and compare the effects of different treatment regimens:estradiol (E2)/sequential combination/continuous combination(E2/DRSP、E2/NET) on breast cancer proliferation. Methods After stabilized transfection by lipofection, T47D cells transfected with vector(T47D-HA-vector) or PGRMC1(T47D-HA-PGRMC1) were stimulated with E2 alone (0.1, 0.01, 0.001 nmol/L), or sequential/continuous combination. CCK-2 method was performed to measure cell proliferation. Results When treated with E2 (0.001, 0.01, 0.1 nmol/L) alone, T47D-HA-vector cells did not show significant proliferation (P>0.05). At concentration of 0.1 nmol/L, T47D-HA-PGRMC1 cell reached a significant increase in cell proliferation compared with the control group (56%, P<0.05) and compared with T47D-HA-vector group (36%, P<0.05); when treated with sequential combination, T47D-HA-PGRMC1 cell under E2/NET treatment (E2=0.001 nmol/L) showed a significant increase in cell proliferation compared with the control group (82%, P<0.05) and T47D-HA-vector group (63%, P<0.05). Under the same stimulation, when the concentration of E2 reached 0.1 nmol/L, T47D-HA-vector showed a significant increase compared with the control group (37%, P<0.05), and for the T47D-HA-PGRMC1 cell line, when under E2/drospirenone (DRSP) or E2/norethisterone (NET) stimulation (E2=0.1 nmol/L), a significant increase compared with the control group (105%, 170%, P<0.05) and T47D-HA-vector group (84%, 133%, P<0.05) was observed; when treated with the continuous combination, the T47D-HA-PGRMC1 cell line showed a significant increase in cell proliferation under E2/DRSP or E2/NET stimulation (E2=0.001 nmol/L) compared with the control group (77%, 158%, P<0.05) and T47D-HA-vector group(60%, 136%, P<0.05). The T47D-HA-vector cell line showed a significant increase under E2/NET stimulation (E2=0.1 nmol/L) compared with the control group (44%, P<0.05), and the T47D-HA-PGRMC1 cell line under E2/DRSP or E2/NET stimulation (E2=0.1 nmol/L) showed a significant increase in cell proliferation compared with the control group (129%, 174%, P<0.05) and T47D-HA-vector group (97%, 131%, P<0.05). Conclusion PGRMC1 can significantly promote the proliferation of breast cancer cells induced by sequential/continuous combination. Compared with the sequential combination, the continuous combination promoted a higher proliferation of T47D.